Hospital
Westmoreland Hospital Association
Westmoreland Hospital Association was paid $6.79M by Medicaid between Jan 2018 and Dec 2024, across 290 billing codes. Its largest line is 99285, emergency room visit (most serious) — 23% of everything it billed.
33Billing provider infoWESTMORELAND HOSPITAL ASSOCIATION
GREENSBURG, PA 15601
GREENSBURG, PA 15601
33aNPI1689691214assigned 07/17/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$6.79M
24GClaims273,065
24DCodes billed290
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Pennsylvania
Rank by total paid#48 of 154
Median peer was paid$2.82M
This provider vs. median2.4×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 729 | $12K | |
| 2019 | 917 | $15K | |
| 2020 | 36,685 | $763K | |
| 2021 | 140,177 | $3.13M | |
| 2022 | 25,358 | $939K | |
| 2023 | 40,779 | $1.11M | |
| 2024incomplete | 28,420 | $821K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 23% | 10,637 | 10,276 | $1.57M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 15% | 9,335 | 9,041 | $995K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 8.5% | 8,189 | 8,002 | $578K |
| G0378 | Hospital observation service, per hour | 4.7% | 452 | 414 | $322K |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 3.4% | 3,543 | 2,304 | $228K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 2.8% | 3,023 | 1,960 | $192K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 2.3% | 1,009 | 986 | $156K |
| T1015 | A visit at a community health center or clinic (one all-in rate)Clinic visit/encounter, all-inclusive | 2.1% | 3,629 | 973 | $139K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 2.0% | 5,236 | 5,023 | $139K |
| 80048 | Basic metabolic panel (calcium, ionized) | 1.9% | 16,935 | 15,486 | $128K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.6% | 24,500 | 22,233 | $112K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 1.2% | 1,642 | 1,467 | $85K |
278 more codes
| 80050 | General health panel | 1.2% | 1,655 | $79K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 1.1% | 2,488 | $74K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 1.1% | 1,452 | $74K |
| 70450 | Computed tomography, head or brain; without contrast material | 1.0% | 1,170 | $69K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 4,274 | $58K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 6,788 | $58K |
| 80053 | Comprehensive metabolic panel | <1% | 7,527 | $57K |
| 80061 | Lipid panel | <1% | 4,461 | $56K |
| 95811 | <1% | 117 | $50K | |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 188 | $46K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 585 | $46K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 2,799 | $45K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 273 | $42K |
| 80076 | <1% | 4,966 | $39K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 1,118 | $37K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 1,195 | $35K |
| 87081 | <1% | 5,458 | $32K | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 168 | $32K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 454 | $30K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 423 | $29K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 3,593 | $29K |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 649 | $27K |
| 71045 | Radiologic examination, chest; single view | <1% | 3,709 | $27K |
| 72141 | <1% | 129 | $26K | |
| 84484 | <1% | 3,118 | $25K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,733 | $24K |
| 81001 | <1% | 8,824 | $22K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 797 | $21K |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 102 | $21K |
| 76830 | Ultrasound, transvaginal | <1% | 470 | $19K |
| 0011A | <1% | 544 | $19K | |
| 0012A | <1% | 451 | $19K | |
| 87428 | <1% | 848 | $18K | |
| 83690 | <1% | 4,040 | $18K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 2,690 | $17K |
| 84466 | <1% | 1,135 | $17K | |
| 93971 | <1% | 259 | $17K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 270 | $16K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 304 | $16K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 494 | $16K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 334 | $15K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 872 | $15K |
| 82607 | <1% | 1,304 | $14K | |
| 73221 | <1% | 59 | $14K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 433 | $14K |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 583 | $14K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 151 | $13K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 2,223 | $13K |
| 86618 | <1% | 564 | $13K | |
| 59025 | Fetal non-stress test | <1% | 1,435 | $13K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 194 | $13K |
| 97162 | <1% | 277 | $13K | |
| 77066 | Tomosynthesis, mammo | <1% | 152 | $12K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 109 | $12K |
| 83735 | <1% | 2,236 | $12K | |
| 82728 | <1% | 1,110 | $12K | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 256 | $11K |
| P9604 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge | <1% | 2,771 | $11K |
| 97597 | <1% | 773 | $10K | |
| 93296 | <1% | 1,068 | $10K | |
| 76642 | <1% | 254 | $10K | |
| 84702 | <1% | 590 | $9K | |
| 76536 | <1% | 209 | $9K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 426 | $9K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 1,560 | $9K |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | <1% | 50 | $9K |
| 83540 | <1% | 1,159 | $9K | |
| 85730 | <1% | 1,687 | $8K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 843 | $8K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 189 | $8K |
| 71250 | <1% | 154 | $8K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 155 | $8K |
| 95806 | <1% | 119 | $8K | |
| 84153 | <1% | 318 | $8K | |
| 85027 | <1% | 1,321 | $8K | |
| 87150 | <1% | 181 | $8K | |
| 97164 | <1% | 207 | $7K | |
| 76775 | <1% | 206 | $7K | |
| 85610 | <1% | 2,891 | $7K | |
| 88342 | <1% | 240 | $7K | |
| 93017 | <1% | 260 | $7K | |
| 83970 | <1% | 205 | $7K | |
| 86803 | <1% | 337 | $6K | |
| 83880 | <1% | 266 | $6K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 592 | $6K |
| 97161 | <1% | 278 | $6K | |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 1,541 | $6K |
| 97010 | <1% | 719 | $6K | |
| 84439 | <1% | 742 | $6K | |
| 82746 | <1% | 509 | $6K | |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 125 | $5K |
| 87522 | Neg quan hep c or qual rna | <1% | 134 | $5K |
| 82043 | <1% | 682 | $5K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 18,456 | $5K |
| 87040 | <1% | 655 | $5K | |
| 82570 | <1% | 745 | $5K | |
| 73610 | <1% | 265 | $5K | |
| 73564 | <1% | 248 | $5K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 325 | $5K |
| 87186 | <1% | 788 | $5K | |
| 86038 | <1% | 315 | $5K | |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | <1% | 259 | $4K |
| 93970 | <1% | 59 | $4K | |
| 77065 | Tomosynthesis, mammo | <1% | 94 | $4K |
| 96376 | <1% | 733 | $4K | |
| 74019 | <1% | 307 | $4K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 182 | $4K |
| 84403 | <1% | 138 | $4K | |
| 86255 | <1% | 219 | $4K | |
| 80081 | <1% | 43 | $4K | |
| 82784 | <1% | 259 | $4K | |
| 0013A | <1% | 90 | $4K | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 393 | $4K |
| 73030 | <1% | 278 | $4K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 182 | $4K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 485 | $4K |
| 73630 | <1% | 380 | $4K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 356 | $4K |
| 87340 | <1% | 245 | $3K | |
| 84481 | <1% | 143 | $3K | |
| 85379 | <1% | 358 | $3K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 92 | $3K |
| 82550 | <1% | 512 | $3K | |
| 76801 | <1% | 75 | $3K | |
| 83615 | <1% | 446 | $3K | |
| 73130 | <1% | 256 | $3K | |
| 72110 | <1% | 147 | $3K | |
| 85652 | <1% | 1,042 | $3K | |
| 84146 | <1% | 128 | $3K | |
| 72100 | <1% | 139 | $3K | |
| 86762 | <1% | 194 | $3K | |
| A9576 | Injection, gadoteridol, (prohance multipack), per ml | <1% | 347 | $2K |
| 87077 | <1% | 497 | $2K | |
| 74018 | <1% | 226 | $2K | |
| 86140 | <1% | 1,032 | $2K | |
| 84436 | <1% | 301 | $2K | |
| 86850 | <1% | 366 | $2K | |
| 73502 | <1% | 144 | $2K | |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 39 | $2K |
| 86617 | <1% | 53 | $2K | |
| 84703 | <1% | 211 | $2K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 41 | $2K |
| 87088 | <1% | 316 | $2K | |
| 82805 | <1% | 60 | $2K | |
| 86706 | <1% | 143 | $2K | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 14 | $2K |
| 83655 | <1% | 151 | $2K | |
| 83605 | <1% | 354 | $2K | |
| 86592 | <1% | 400 | $2K | |
| 82565 | <1% | 301 | $2K | |
| 82950 | <1% | 215 | $2K | |
| 82248 | <1% | 239 | $1K | |
| G0328 | Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | <1% | 88 | $1K |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results | <1% | 98 | $1K |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | <1% | 103 | $1K |
| 87070 | <1% | 317 | $1K | |
| 84550 | <1% | 292 | $1K | |
| 84100 | <1% | 315 | $1K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 71 | $1K |
| 80164 | <1% | 102 | $1K | |
| 77080 | <1% | 27 | $1K | |
| 86431 | <1% | 163 | $1K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 538 | $1K |
| J2785 | Injection, regadenoson, 0.1 mg | <1% | 30 | $1K |
| 73110 | <1% | 116 | $1K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 14 | $1K |
| 85018 | <1% | 424 | $1K | |
| 85014 | <1% | 416 | $1K | |
| 86901 | <1% | 347 | $1K | |
| 86787 | <1% | 63 | $1K | |
| 86900 | <1% | 346 | $1K | |
| 82105 | <1% | 57 | $1K | |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | <1% | 30 | $1K |
| 84520 | <1% | 231 | $1K | |
| 84480 | <1% | 137 | $998.70 | |
| 81025 | <1% | 457 | $964.80 | |
| 86480 | <1% | 15 | $963.35 | |
| 70486 | <1% | 15 | $947.05 | |
| 83001 | <1% | 52 | $885.15 | |
| 82948 | <1% | 1,204 | $845.98 | |
| 87147 | <1% | 253 | $801.77 | |
| 86800 | <1% | 39 | $769.23 | |
| 84425 | <1% | 104 | $729.35 | |
| 84402 | <1% | 25 | $724.14 | |
| 82525 | <1% | 59 | $706.44 | |
| 80055 | <1% | 130 | $686.16 | |
| 80177 | <1% | 58 | $644.64 | |
| 82140 | <1% | 173 | $631.05 | |
| 86225 | <1% | 44 | $630.95 | |
| 94729 | <1% | 24 | $602.68 | |
| 29125 | <1% | 26 | $578.76 | |
| 83921 | <1% | 43 | $577.73 | |
| 73562 | <1% | 42 | $571.88 | |
| 76870 | <1% | 14 | $570.11 | |
| 83516 | <1% | 226 | $560.22 | |
| 80069 | <1% | 85 | $534.72 | |
| 84590 | <1% | 43 | $517.19 | |
| 73590 | <1% | 35 | $511.74 | |
| 73080 | <1% | 45 | $479.07 | |
| 84460 | <1% | 81 | $471.58 | |
| 82977 | <1% | 59 | $469.01 | |
| 86665 | <1% | 21 | $454.28 | |
| 87075 | <1% | 91 | $452.90 | |
| 86376 | <1% | 52 | $436.56 | |
| 82274 | <1% | 155 | $435.90 | |
| 82947 | <1% | 139 | $432.96 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 3,027 | $409.14 |
| 86235 | <1% | 13 | $406.44 | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 1,364 | $394.42 |
| 84165 | <1% | 26 | $391.84 | |
| A9270 | Non-covered item or service | <1% | 1,329 | $371.27 |
| 87205 | <1% | 167 | $369.55 | |
| Q3014 | Telehealth originating site facility fee | <1% | 154 | $369.29 |
| 84156 | <1% | 107 | $352.65 | |
| 87505 | <1% | 12 | $338.91 | |
| 72050 | <1% | 13 | $323.97 | |
| J3490 | Unclassified drugs | <1% | 1,085 | $320.86 |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 26 | $318.24 |
| 97165 | <1% | 31 | $305.43 | |
| 94726 | <1% | 12 | $276.75 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 259 | $273.66 |
| 83002 | <1% | 15 | $266.22 | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 42 | $265.21 |
| 90715 | <1% | 25 | $245.91 | |
| J0780 | Injection, prochlorperazine, up to 10 mg | <1% | 130 | $224.99 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 4,342 | $223.83 |
| 94060 | <1% | 25 | $220.54 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 1,056 | $205.79 |
| 84145 | <1% | 32 | $191.45 | |
| 86039 | <1% | 14 | $186.27 | |
| 96367 | <1% | 13 | $173.90 | |
| 86708 | <1% | 13 | $170.93 | |
| 84630 | <1% | 13 | $166.34 | |
| 82150 | <1% | 37 | $157.50 | |
| 93246 | <1% | 12 | $155.98 | |
| J1790 | Injection, droperidol, up to 5 mg | <1% | 53 | $153.13 |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 61 | $136.68 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 232 | $127.54 |
| 84446 | <1% | 13 | $125.10 | |
| J3411 | Injection, thiamine hcl, 100 mg | <1% | 51 | $124.86 |
| J2060 | Injection, lorazepam, 2 mg | <1% | 635 | $119.15 |
| 80175 | <1% | 12 | $110.28 | |
| 84450 | <1% | 14 | $89.14 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 790 | $78.12 |
| S0028 | Injection, famotidine, 20 mg | <1% | 17 | $57.45 |
| 84132 | <1% | 28 | $50.32 | |
| 88304 | <1% | 60 | $44.46 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 201 | $42.52 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,157 | $40.82 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 179 | $38.95 |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | <1% | 142 | $37.63 |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 183 | $32.99 |
| C9113 | Injection, pantoprazole sodium, per vial | <1% | 74 | $23.90 |
| J2704 | Injection, propofol, 10 mg | <1% | 1,403 | $21.29 |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 406 | $20.73 |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | <1% | 42 | $17.19 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 1,098 | $11.37 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 15 | $11.00 |
| J3480 | Injection, potassium chloride, per 2 meq | <1% | 15 | $10.85 |
| J7060 | 5% dextrose/water (500 ml = 1 unit) | <1% | 43 | $7.92 |
| 3044F | <1% | 382 | $4.83 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 1,027 | $3.76 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 0% | 43 | $0.00 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 0% | 228 | $0.00 |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | 0% | 16 | $0.00 |
| 3046F | 0% | 33 | $0.00 | |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | 0% | 18 | $0.00 |
| J0136 | Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mg | 0% | 585 | $0.00 |
| J1171 | Injection, hydromorphone, 0.1 mg | 0% | 57 | $0.00 |
| J2272 | Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg | 0% | 62 | $0.00 |
| 3051F | 0% | 58 | $0.00 | |
| 93325 | 0% | 13 | $0.00 | |
| J1040 | Injection, methylprednisolone acetate, 80 mg | 0% | 14 | $0.00 |
| A9579 | Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml | 0% | 197 | $0.00 |
| 88341 | 0% | 28 | $0.00 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 0% | 443 | $0.00 |
| 3052F | 0% | 13 | $0.00 | |
| J1815 | Injection, insulin, per 5 units | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialCURRY, JEFFREY (EXECUTIVE VICE PRESIDENT CFO)
| Provider | Location | Paid |
|---|---|---|
| Frick Hospital | Mt Pleasant, PA | $5.60M |
| Latrobe Area Hospital, INC. | Latrobe, PA | $4.86M |
| Westmoreland Regional Hospital | Greensburg, PA | $3.06M |
| Latrobe Area Hospital | Latrobe, PA | $2.96M |
| Frick Hospital | Mt Pleasant, PA | $228K |
| Westmoreland Regional Hospital | Greensburg, PA | $34K |
| Westmoreland Regional Hospital | North Huntington, PA | $1K |
| Westmoreland Regional Hospital | Greensboro, PA | $35.05 |
| Latrobe Area Hospital | Latrobe, PA | $0.00 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.